Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 152

Related Citations for PubMed (Select 21947629)

1.

Effects of additional blood pressure and lipid measurements on the prediction of cardiovascular risk.

Bell K, Hayen A, McGeechan K, Neal B, Irwig L.

Eur J Prev Cardiol. 2012 Dec;19(6):1474-85. doi: 10.1177/1741826711424494. Epub 2011 Sep 26.

PMID:
21947629
2.

A multiple biomarker risk score for guiding clinical decisions using a decision curve approach.

Hughes MF, Saarela O, Blankenberg S, Zeller T, Havulinna AS, Kuulasmaa K, Yarnell J, Schnabel RB, Tiret L, Salomaa V, Evans A, Kee F; MORGAM project.

Eur J Prev Cardiol. 2012 Aug;19(4):874-84. doi: 10.1177/1741826711417341. Epub 2011 Jul 20.

PMID:
21775414
3.

Sex-specific differences in the predictive value of cholesterol homeostasis markers and 10-year cardiovascular disease event rate in Framingham Offspring Study participants.

Matthan NR, Zhu L, Pencina M, D'Agostino RB, Schaefer EJ, Lichtenstein AH.

J Am Heart Assoc. 2013 Feb 19;2(1):e005066. doi: 10.1161/JAHA.112.005066.

4.

Risk prediction of incident coronary heart disease in The Netherlands: re-estimation and improvement of the SCORE risk function.

Merry AH, Boer JM, Schouten LJ, Ambergen T, Steyerberg EW, Feskens EJ, Verschuren WM, Gorgels AP, van den Brandt PA.

Eur J Prev Cardiol. 2012 Aug;19(4):840-8. doi: 10.1177/1741826711410256. Epub 2011 May 6.

PMID:
21551214
5.

Do obesity and parental history of myocardial infarction improve cardiovascular risk prediction?

van Dis I, Geleijnse JM, Kromhout D, Boer J, Boshuizen H, Verschuren WM.

Eur J Prev Cardiol. 2013 Oct;20(5):793-9. doi: 10.1177/2047487312444233. Epub 2012 Mar 28.

PMID:
22456690
6.

The effect of including C-reactive protein in cardiovascular risk prediction models for women.

Cook NR, Buring JE, Ridker PM.

Ann Intern Med. 2006 Jul 4;145(1):21-9.

PMID:
16818925
7.

How much does HDL cholesterol add to risk estimation? A report from the SCORE Investigators.

Cooney MT, Dudina A, De Bacquer D, Fitzgerald A, Conroy R, Sans S, Menotti A, De Backer G, Jousilahti P, Keil U, Thomsen T, Whincup P, Graham I; SCORE Investigators.

Eur J Cardiovasc Prev Rehabil. 2009 Jun;16(3):304-14. doi: 10.1097/HJR.0b013e3283213140.

PMID:
19609139
8.

Should pulse pressure become part of the Framingham risk score?

Nawrot TS, Staessen JA, Thijs L, Fagard RH, Tikhonoff V, Wang JG, Franklin SS.

J Hum Hypertens. 2004 Apr;18(4):279-86.

PMID:
15037878
9.

Lipid-related markers and cardiovascular disease prediction.

Emerging Risk Factors Collaboration, Di Angelantonio E, Gao P, Pennells L, Kaptoge S, Caslake M, Thompson A, Butterworth AS, Sarwar N, Wormser D, Saleheen D, Ballantyne CM, Psaty BM, Sundström J, Ridker PM, Nagel D, Gillum RF, Ford I, Ducimetiere P, Kiechl S, Koenig W, Dullaart RP, Assmann G, D'Agostino RB Sr, Dagenais GR, Cooper JA, Kromhout D, Onat A, Tipping RW, Gómez-de-la-Cámara A, Rosengren A, Sutherland SE, Gallacher J, Fowkes FG, Casiglia E, Hofman A, Salomaa V, Barrett-Connor E, Clarke R, Brunner E, Jukema JW, Simons LA, Sandhu M, Wareham NJ, Khaw KT, Kauhanen J, Salonen JT, Howard WJ, Nordestgaard BG, Wood AM, Thompson SG, Boekholdt SM, Sattar N, Packard C, Gudnason V, Danesh J.

JAMA. 2012 Jun 20;307(23):2499-506. doi: 10.1001/jama.2012.6571.

10.

Combining risk markers improves cardiovascular risk prediction in women.

Holewijn S, den Heijer M, Kiemeney LA, Stalenhoef AF, de Graaf J.

Clin Sci (Lond). 2014 Jan;126(2):139-46. doi: 10.1042/CS20130178.

PMID:
23879211
11.

Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels.

Grover SA, Kaouache M, Joseph L, Barter P, Davignon J.

Arch Intern Med. 2009 Oct 26;169(19):1775-80. doi: 10.1001/archinternmed.2009.328.

PMID:
19858435
12.
13.

Predicting the 30-year risk of cardiovascular disease: the framingham heart study.

Pencina MJ, D'Agostino RB Sr, Larson MG, Massaro JM, Vasan RS.

Circulation. 2009 Jun 23;119(24):3078-84. doi: 10.1161/CIRCULATIONAHA.108.816694. Epub 2009 Jun 8.

14.

[Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].

Vanuzzo D, Pilotto L, Mirolo R, Pirelli S.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):6S-17S. Review. Italian.

PMID:
18773746
15.

Assessment of the value of a genetic risk score in improving the estimation of coronary risk.

Lluis-Ganella C, Subirana I, Lucas G, Tomás M, Muñoz D, Sentí M, Salas E, Sala J, Ramos R, Ordovas JM, Marrugat J, Elosua R.

Atherosclerosis. 2012 Jun;222(2):456-63. doi: 10.1016/j.atherosclerosis.2012.03.024. Epub 2012 Mar 30.

16.

A consultation-based method is equal to SCORE and an extensive laboratory-based method in predicting risk of future cardiovascular disease.

Petersson U, Ostgren CJ, Brudin L, Nilsson PM.

Eur J Cardiovasc Prev Rehabil. 2009 Oct;16(5):536-40. doi: 10.1097/HJR.0b013e32832b1833.

PMID:
19357517
17.

Cardiovascular risk prediction in diabetic men and women using hemoglobin A1c vs diabetes as a high-risk equivalent.

Paynter NP, Mazer NA, Pradhan AD, Gaziano JM, Ridker PM, Cook NR.

Arch Intern Med. 2011 Oct 24;171(19):1712-8. doi: 10.1001/archinternmed.2011.351. Epub 2011 Jul 25.

19.

[Discriminative ability, reclassification and net benefit: the predictive value of biomarkers].

Steyerberg EW, Pencina MJ, Van Calster B.

Ned Tijdschr Geneeskd. 2012;156(41):A5029. Review. Dutch.

PMID:
23062255
20.

The systolic blood pressure difference between arms and cardiovascular disease in the Framingham Heart Study.

Weinberg I, Gona P, O'Donnell CJ, Jaff MR, Murabito JM.

Am J Med. 2014 Mar;127(3):209-15. doi: 10.1016/j.amjmed.2013.10.027. Epub 2013 Nov 25.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk